General Information

Dr. Adam D. Cohen, Chair
Institutional Review Board

The purpose of the Institutional Review Board (IRB) is to protect human subjects involved in research. After review by the Research Review Committee (RRC), each protocol involving human subjects is initially reviewed by the Board and, if approved, is reviewed on a continuing basis. A progress report and updated consent form are submitted to and reviewed by the Board at least annually and more frequently if needed.

Common Questions

• What is an IRB? (This link requires Microsoft® Word to view.)
• Refer to the Belmont Report Summary
• Refer to the Declaration of Helsinki
• What Are Clinical Trials?
• Find a Clinical Trial at FCCC
• Understanding Insurance Coverage in Clinical Trials

Helpful Information

• National Cancer Institute: Information on Clinical Trials
• National Cancer Institute: Cancer Topics
• Pamphlet: Becoming a Research Volunteer (PDF)
• Glossary of Clinical Trial Terms
• NIH: Dictionary of Cancer Terms

Other Links

• Fox Chase Cancer Center Partners
• For procedure: Fox Chase Cancer Center Protocol Office

Links to Regulations

• United States Department of Health and Human Services
• United States Food and Drug Association

To discuss problems, concerns and/or questions please use the contact information below:

Fox Chase Cancer Center
Institutional Review Board
50 Huntingdon Pike
Second floor
Rockledge, PA 19046
Phone: 215-214-3754